未登录 分享 收藏
分享 收藏
Integrating machine learning prediction and causal inference analysis to unravel determinants of progression in EGFR-mutant, advanced NSCLC 整合机器学习预测与因果推断分析，以揭示EGFR突变、晚期非小细胞肺癌进展的决定因素 Bozcuk, H.; Sert, L.; Kaplan, M. A.; Tatli, A. M.; Karaca, M.; Kilictas, B.; Artac, M.; Sendur, M. A. N.; Bilgin, B.; Balli, S.; Demirkazik, A.; Kilickap, S.; Taban, H.; Guzel, H. G.; Kocer, M.; Koylu, B.; Biricik, F. S.; Karakaya, G.; Coskun, H. S.; Alemdar, M. S. 分享 收藏
Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA) Ozkan, M.; Cicin, I.; Ozaslan, E.; Benekli, M.; Oksuzoglu, B.; Kocer, M.; Isikdogan, A.; Sevinc, A.; Karaoglu, A.; Dane, F.; Cubukcu, E.; Elkiran, E. T.; Aliustaoglu, M. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology 接受拉帕替尼联合卡培他滨联合治疗的HER2-positive乳腺癌脑转移患者的临床结局以及与接受曲妥珠单抗治疗的患者的生存率比较: 安那托利亚医学肿瘤学会的一项研究 Kaplan, Muhammet Ali; Isikdogan, Abdurrahman; Koca, Dogan; Kucukoner, Mehmet; Gumusay, Ozge; Yildiz, Ramazan; Dayan, Adem; Demir, Lutfiye; Geredeli, Caglayan; Kocer, Murat; Arslan, Ulku Yalcintas; Inal, Ali; Akman, Tulay; Coskun, Ugur; Sener, Nur; Inanc, Mevlude; Elkiran, Emin Tamer; Ozdemir, Nuriye Yildirim; Durnali, Ayse Gok; Suner, Ali; Alici, Suleyman; Tarhan, Mustafa Oktay; Boruban, Cem; Oksuzoglu, Berna; Urakci, Zuhat 分享 收藏
ABO and Rh Blood Groups Frequency in Women With HER2(+) Breast Cancer Urun, Y.; Utkan, G.; Altundag, K.; Arslan, O.; Onur, H.; Arslan, U. Y.; Kocer, M.; Dogan, I.; Yalcin, B.; Icli, F. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BREAST CANCER.png)
.png){kind=icon}
分享.png){kind=icon}
收藏